Primary information |
---|
ID | antitb_1950, |
Name | 28275372 |
N-Terminal modification | NDBP-5 |
C-Terminal Modification | IFSAIAGLLSNLL |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 13 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from scorpion hadrurus gertschi |
Inhibition Concentration | Mycobacterium abscessus |
In Vitro/ In vivo | Mycobacterium abscessus subsp. Massiliene GO01 |
Cell Line | MIC = 100 μM |
Inhibition Concentration | In vitro |
Sequence | 2017 |
Cytotoxicity | Human erythrocyte |
In vivo Model | NA |
Lethal Dose | No cytotoxicity |
Immune Responce | BALB/c mice |
Mechanism of Action | 2mg/kg |
Target | IFN-y production |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1951, |
Name | 28275372 |
N-Terminal modification | NDBP-5 |
C-Terminal Modification | IFSAIAGLLSNLL |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 13 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from scorpion hadrurus gertschi |
Inhibition Concentration | Mycobacterium abscessus |
In Vitro/ In vivo | Mycobacterium abscessus subsp. Massiliene GO06 |
Cell Line | MIC = 100 μM |
Inhibition Concentration | In vitro |
Sequence | 2017 |
Cytotoxicity | Human erythrocyte |
In vivo Model | NA |
Lethal Dose | No cytotoxicity |
Immune Responce | BALB/c mice |
Mechanism of Action | 2mg/kg |
Target | IFN-y production |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1952, |
Name | 28275372 |
N-Terminal modification | NDBP-5 |
C-Terminal Modification | IFSAIAGLLSNLL |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 13 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from scorpion hadrurus gertschi |
Inhibition Concentration | Mycobacterium abscessus |
In Vitro/ In vivo | Mycobacterium abscessus subsp. Massiliene GO08 |
Cell Line | MIC = 100 μM |
Inhibition Concentration | In vitro |
Sequence | 2017 |
Cytotoxicity | Human erythrocyte |
In vivo Model | NA |
Lethal Dose | No cytotoxicity |
Immune Responce | BALB/c mice |
Mechanism of Action | 2mg/kg |
Target | IFN-y production |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | NA |
Tertiary Structure (Technique) | Not Predicted), |